“…skinfold) [ 70 – 76 ], monitoring growth patterns [ 54 , 77 – 80 ], investigating the relationship between maternal and prenatal factors and health outcomes during infancy [ 81 – 86 ], and others [ 87 ]. The majority of these studies ( n = 43) included only full-term infants [ 33 , 52 – 54 , 56 – 58 , 60 , 62 , 66 , 67 , 69 – 72 , 74 , 75 , 78 , 80 , 81 , 83 – 86 , 88 – 106 ], 13 only pre-term infants [ 9 , 68 , 73 , 77 , 79 , 107 – 112 ], and 17 both full- and pre-term infants [ 55 , 59 , 61 , 63 – 65 , 76 , 82 , 87 , 113 – 120 ]. Although, the use of Pea Pod in both full-term and pre-term infants and in specific clinical risk and ethnic groups is feasible, it might be associated with some practical challenges.…”